Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis

Fig. 1

Flow cytometry gating example. Representative flow cytometry dot plots of CD19+CD22+ B cells. a Brefeldin A (BFA)-treated samples. b Phorbol myristate acetate (PMA)- and calcium ionophore (CaI)-stimulated, BFA-treated samples. c CpG-oligodeoxynucleotide (CpG-ODN)-stimulated, BFA-treated samples. d CpG-ODN-, PMA-, and CaI-stimulated, BFA-treated samples. To determine the percentage of B cells positive for cytokine production (a) and (c) were used as negative controls to set the gates for (b) and (d), respectively

Back to article page